Detalles de la búsqueda
1.
Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G).
Oncologist
; 29(3): e330-e336, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950903
2.
The efficacy and safety of anamorelin among patients with diabetes.
Int J Clin Oncol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722487
3.
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
Br J Cancer
; 129(6): 1032-1039, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532830
4.
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.
Oncologist
; 28(11): e1108-e1113, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37284901
5.
Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients.
J Hum Genet
; 68(2): 81-86, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36482120
6.
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
BMC Cancer
; 23(1): 726, 2023 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37543568
7.
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin.
BMC Cancer
; 23(1): 68, 2023 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36670426
8.
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases.
BMC Cancer
; 23(1): 779, 2023 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37605122
9.
Clinical outcomes of intensive versus less intensive first-line chemotherapy for metastatic colorectal cancer.
Future Oncol
; 19(39): 2569-2583, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37387237
10.
Immune checkpoint inhibitor therapy in neoadjuvant and adjuvant treatment for cancer: A paradigm shift in the treatment of resectable gastrointestinal cancer 3)A paradigm shift in the treatment of colorectal cancer.
Int J Clin Oncol
; 28(11): 1442-1450, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37668816
11.
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutant.
Int J Clin Oncol
; 28(5): 654-663, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36856908
12.
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA
; 329(15): 1271-1282, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071094
13.
Toxic Effects of Two Redox States of Thallium on Immortalised Hypothalamic GT1-7 Neuronal Cells.
Int J Mol Sci
; 24(14)2023 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37511342
14.
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy.
Cancer Sci
; 113(4): 1531-1534, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34839585
15.
The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion.
Ann Surg Oncol
; 29(8): 4992-5002, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35368218
16.
Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a single-center retrospective cohort study.
Invest New Drugs
; 40(5): 1106-1116, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35900709
17.
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.
Int J Clin Oncol
; 27(9): 1450-1458, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35861943
18.
[Treatment Strategy with Immune Checkpoint Inhibitors and Genetic Testing for Colorectal Cancer with Microsatellite Instability-High].
Gan To Kagaku Ryoho
; 49(7): 761-767, 2022 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-35851347
19.
FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.
Cancer Sci
; 112(1): 314-322, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33075166
20.
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study.
Oncologist
; 26(10): 845-853, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34232546